Literature DB >> 34344345

Case report: aseptic meningitis secondary to varicella-zoster virus (VZV) without an exanthem post MMR vaccination.

Syeda Sahra1, Abdullah Jahangir2, Allison Glaser2, Neville Mobarakai2, Ahmad Jahangir3.   

Abstract

BACKGROUND: Varicella-zoster virus (VZV) is a known cause of aseptic meningitis, with a predisposition for an immunocompromised population. A dermatomal rash usually accompanies aseptic meningitis secondary to VZV. CASE
PRESENTATION: We report the case of a 31-year-old male with a history of chickenpox in childhood and recent shingles who presented with severe frontal headaches secondary to VZV meningitis. The patient had also recently received the measles-mumps-rubella (MMR) vaccine. He recovered without any neurological sequala.
CONCLUSION: This case report describes an immunocompetent patient with recent MMR vaccination who developed aseptic meningitis secondary to VZV without any dermatomal involvement (Zoster Sine Herpete).
© 2021. The Author(s).

Entities:  

Keywords:  Aseptic meningitis; Chickenpox; MMR; Shingles; VZV; Zoster

Year:  2021        PMID: 34344345     DOI: 10.1186/s12879-021-06453-5

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  21 in total

Review 1.  Neurologic complications of the reactivation of varicella-zoster virus.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; J J LaGuardia; R Mahalingam; R J Cohrs
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

2.  Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

Authors:  Sérgio Souza da Cunha; Laura C Rodrigues; Maurício L Barreto; Inês Dourado
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

3.  Zoster sine herpete.

Authors:  G W LEWIS
Journal:  Br Med J       Date:  1958-08-16

4.  Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

Authors:  I Dourado; S Cunha; M G Teixeira; C P Farrington; A Melo; R Lucena; M L Barreto
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

5.  Adverse events associated with MMR vaccines in Japan.

Authors:  M Kimura; H Kuno-Sakai; S Yamazaki; A Yamada; M Hishiyama; H Kamiya; K Ueda; T Murase; M Hirayama; A Oya; S Nozaki; R Murata
Journal:  Acta Paediatr Jpn       Date:  1996-06

6.  Aseptic meningitis after measles-mumps-rubella (MMR) vaccination.

Authors:  Setareh Mamishi; Maryam Sarkardeh; Babak Pourakbari; Sepideh Keshavarz Valian; Farah Sabouni; Shima Mahmoudi
Journal:  Br J Biomed Sci       Date:  2016-05-05       Impact factor: 3.829

7.  Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998.

Authors:  W O Arruda; C Kondageski
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2001 Sep-Oct       Impact factor: 1.846

8.  The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.

Authors:  Claudio Marcos da Silveira; Claudete Iris Kmetzsch; Renate Mohrdieck; Alethea Fagundes Sperb; D Rebecca Prevots
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

9.  [Aseptic meningitis after mumps vaccination].

Authors:  E Autret; A P Jonville-Béra; C Galy-Eyraud; L Hessel
Journal:  Therapie       Date:  1996 Nov-Dec       Impact factor: 2.070

10.  Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-Mérieux Sérums & Vaccins.

Authors:  A P Jonville-Bera; E Autret; C Galy-Eyraud; L Hessel
Journal:  Pharmacoepidemiol Drug Saf       Date:  1996-01       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.